NoAAC PR-02 Study

Study Description: This study intends to create a multi-institutional prospective cohort idiopathic subglottic stenosis (iSGS) patients, and enable rigorous treatment strategies comparisons to determine the most common treatment of iSGS work and determine the quality of life trade-offs are associated with each treatment approch. This rigorous prospective treatment comparisons will provide information to patients so that they can answer the following questions; 1) give my personal characteristics, conditions and preferences, what should I expect will happen to me? and 2) what are my options and what are the potential benefits and harms of these options? The primary endpoint is treatment effectiveness - time to recurrent procedure and need for tracheostomy, and the secondary endpoint is health and quality of life trade offs - patient reported outcome measures in voice, swallowing, breathing, and global quality of life.

Contact for Enrollment

     (706) 721-6100

    Submit Information Online

Principal Investigator: Gregory Postma

Eligibility Criteria: All clinically confirmed iSGS patients at the participating institutions, who are over 18 years of age, are eligible for enrollment.

Compensation: No, subjects will not be compensated.


Didn't find a study to participate in?

If you don't see specific studies that interest you, please submit your contact information for future studies.